Anzeige
Mehr »
Dienstag, 11.08.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A41UNJ | ISIN: US1897632048 | Ticker-Symbol: C970
NASDAQ
11.08.26 | 16:50
1,520 US-Dollar
+1,33 % +0,020
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
CO-DIAGNOSTICS INC Chart 1 Jahr
5-Tage-Chart
CO-DIAGNOSTICS INC 5-Tage-Chart

Aktuelle News zur CO-DIAGNOSTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoCo-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test166Submission includes a concurrent CLIA Waiver by Application for use of the test on the Co-Dx PCR Pro® instrument in decentralized point-of-care settings SALT LAKE...
► Artikel lesen
28.07.EXCLUSIVE: Co-Diagnostics Announces Successful Proof of Concept for Extraction-Free Ebola Test8
27.07.Co-Diagnostics, Inc. - 8-K, Current Report8
22.07.Co-Diagnostics joint venture begins TB test clinical studies in India5
22.07.EXCLUSIVE: Co-Diagnostics Marks New Milestone as India TB Test Clinical Studies Begin15
16.07.Co-Diagnostics Appoints Wes Lindsey, PhD, MBA as Chief Scientific Officer191SALT LAKE CITY, July 16, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented...
► Artikel lesen
01.07.Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care Test265More than 1,400 patients enrolled across 9 clinical sites; analytical performance testing included 27 individual studies and over 10,000 PCR test cup runs Analytical...
► Artikel lesen
CO-DIAGNOSTICS Aktie jetzt für 0€ handeln
01.07.EXCLUSIVE: Co-Diagnostics Reaches Regulatory Milestone for PCR Respiratory Test Platform13
18.06.Co-Diagnostics hosts Saudi joint venture for manufacturing tour2
18.06.Co-Diagnostics treibt Technologietransfer an saudisches Joint Venture voran3
11.06.Co-Diagnostics sichert sich Exklusivvertrieb in Mexiko32
11.06.Co-Diagnostics signs exclusive Mexico distribution deal9
28.05.Is Co-Diagnostics National Security's Next Diagnostic Pick?23
21.05.Co-Diagnostics, Inc. - 8-K, Current Report31
20.05.What's Going On With Co-Diagnostics Stock Wednesday?13
20.05.Co-Diagnostics jumps 11%, raises $3M privately4
20.05.Co-Diagnostics announces $3 million private placement13
15.05.Co-Diagnostics anticipates filing FDA 510(k) in the third quarter as CoSara expands TAM to approximately $13B20
14.05.Co-Diagnostics Q1 2026 Earnings Call Transcript2
14.05.Co-Diagnostics, Inc. - 10-Q, Quarterly Report6
Weiter >>
47 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1